Opella Healthcare Group SAS, a Sanofi Company
3 clinical trials · Sponsor
◉ Watch Opella Healthcare Group SAS, a Sanofi Company
| Record | Firm | Date |
|---|---|---|
| Bioavailability Study of Magne-B6 New Formulation (NCT06386211) | Opella Healthcare Group SAS, a Sanofi Company | 2024-07-03 |
| Bioavailability Study of Fexofenadine HCl New Formulation Tablet (NCT06284902) | Opella Healthcare Group SAS, a Sanofi Company | 2024-02-23 |
| A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis (NCT05692154) | Opella Healthcare Group SAS, a Sanofi Company | 2023-01-23 |
Track Opella Healthcare Group SAS, a Sanofi Company automatically
Every clearance here is in the API, with alerts when new ones post.